Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Association Between Proton Pump Inhibitors and Hematologic Toxicity of Pemetrexed (NCT03537833) | CHU de Reims | 2018-05-02 |
Track Patients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.